The Rigidins: Isolation, Bioactivity, and Total Synthesis-Novel Pyrrolo[2,3-d]Pyrimidine Analogues Using Multicomponent Reactions.

Q1 Biochemistry, Genetics and Molecular Biology
Alkaloids: Chemistry and Biology Pub Date : 2018-01-01 Epub Date: 2018-02-06 DOI:10.1016/bs.alkal.2017.12.003
Aletta E van der Westhuyzen, Liliya V Frolova, Alexander Kornienko, Willem A L van Otterlo
{"title":"The Rigidins: Isolation, Bioactivity, and Total Synthesis-Novel Pyrrolo[2,3-d]Pyrimidine Analogues Using Multicomponent Reactions.","authors":"Aletta E van der Westhuyzen,&nbsp;Liliya V Frolova,&nbsp;Alexander Kornienko,&nbsp;Willem A L van Otterlo","doi":"10.1016/bs.alkal.2017.12.003","DOIUrl":null,"url":null,"abstract":"<p><p>Rigidins (2-6) are pyrrolopyrimidine alkaloids isolated from marine tunicates. Since their isolation, refinement of their total syntheses, and biochemical evaluation, interest toward this pyrrolo[2,3-d]pyrimidine scaffold as a medicinal candidate has been triggered. The derivatization of these natural products has led to the discovery of a novel range of 7-deazahypoxanthines, which exhibit extremely potent anticancer activity in human cancer cell lines. A major breakthrough toward the synthesis of rigidin and various rigidin analogues has been the application of multicomponent reactions (MCRs). The rapid assembly of molecular diversity and flexibility displayed by MCRs makes it an attractive strategy for the preparation of rigidin-inspired small molecules. Furthermore, a number of rigidin-like 7-deazaxanthine compounds have been reported in the literature and the popularity of implementing MCRs to construct these 7-deazaxanthines is highlighted here. It is our hope that the synthetic methods described in this chapter will result in the further generation of rigidin-inspired compounds that will move on from being \"hits\" into \"leads\" in the medicinal chemistry drug discovery pipeline and potentially into anticancer therapeutics.</p>","PeriodicalId":35785,"journal":{"name":"Alkaloids: Chemistry and Biology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/bs.alkal.2017.12.003","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alkaloids: Chemistry and Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/bs.alkal.2017.12.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/2/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 4

Abstract

Rigidins (2-6) are pyrrolopyrimidine alkaloids isolated from marine tunicates. Since their isolation, refinement of their total syntheses, and biochemical evaluation, interest toward this pyrrolo[2,3-d]pyrimidine scaffold as a medicinal candidate has been triggered. The derivatization of these natural products has led to the discovery of a novel range of 7-deazahypoxanthines, which exhibit extremely potent anticancer activity in human cancer cell lines. A major breakthrough toward the synthesis of rigidin and various rigidin analogues has been the application of multicomponent reactions (MCRs). The rapid assembly of molecular diversity and flexibility displayed by MCRs makes it an attractive strategy for the preparation of rigidin-inspired small molecules. Furthermore, a number of rigidin-like 7-deazaxanthine compounds have been reported in the literature and the popularity of implementing MCRs to construct these 7-deazaxanthines is highlighted here. It is our hope that the synthetic methods described in this chapter will result in the further generation of rigidin-inspired compounds that will move on from being "hits" into "leads" in the medicinal chemistry drug discovery pipeline and potentially into anticancer therapeutics.

刚性蛋白:分离、生物活性和全合成——新型吡咯[2,3-d]嘧啶类似物的多组分反应。
刚性蛋白(2-6)是从海洋被囊动物中分离出来的吡咯嘧啶类生物碱。由于它们的分离,它们的全合成的改进和生化评价,对这种吡咯[2,3-d]嘧啶支架作为药物候选物的兴趣已经被触发。这些天然产物的衍生化导致了一系列新的7-二氮杂亚黄嘌呤的发现,这些黄嘌呤在人类癌细胞系中表现出极强的抗癌活性。刚性蛋白和各种刚性蛋白类似物合成的一个重大突破是多组分反应(mcr)的应用。mcr所显示的分子多样性和灵活性的快速组装使其成为制备刚体激发小分子的一种有吸引力的策略。此外,文献中已经报道了许多类似刚性蛋白的7-去氮杂黄嘌呤化合物,本文强调了利用mcr构建这些7-去氮杂黄嘌呤的流行。我们希望本章中描述的合成方法将导致进一步产生刚性蛋白激发的化合物,这些化合物将从药物化学药物发现管道中的“热门”变为“先导”,并有可能成为抗癌治疗药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Alkaloids: Chemistry and Biology
Alkaloids: Chemistry and Biology Biochemistry, Genetics and Molecular Biology-Biochemistry
CiteScore
13.70
自引率
0.00%
发文量
21
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信